(VIANEWS) – American Public Education (APEI), Huntington Bancshares (HBAN), First Solar (FSLR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. American Public Education (APEI)

76.3% sales growth and 7.15% return on equity

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education.

American Public Education’s sales growth this year is expected to be 25.2% and 56.7% for next year.

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 335.71M for the twelve trailing months.

Volume

Today’s last reported volume for American Public Education is 109678 which is 41.3% above its average volume of 77618.

American Public Education’s sales growth is a negative 0% for the current quarter and 76.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 94.4% and negative -17%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.15%.

Volatility

American Public Education’s last day, last week, and last month’s current intraday variation average was 3.93%, 1.22%, and 1.59%, respectively.

American Public Education’s highest amplitude of average volatility was 5.39% (day), 2.17% (last week), and 2.79% (last month), respectively.

American Public Education’s Stock Yearly Top and Bottom Value

American Public Education’s stock is valued at $24.62 at 00:22 EST, way under its 52-week high of $39.19 and higher than its 52-week low of $23.88.

American Public Education’s Moving Average

American Public Education’s worth is below its 50-day moving average of $25.52 and way below its 200-day moving average of $27.47.

2. Huntington Bancshares (HBAN)

37.6% sales growth and 6.92% return on equity

Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.

Huntington Bancshares’s sales growth this year is expected to be 24.8% and 13.1% for next year.

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 4.69B for the twelve trailing months.

Volume

Today’s last reported volume for Huntington Bancshares is 10159000 which is 12.27% below its average volume of 11580600.

Huntington Bancshares’s sales growth is a negative 0% for the ongoing quarter and 37.6% for the next. The company’s growth estimates for the current quarter and the next is 22.2% and 25.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.92%.

Volatility

Huntington Bancshares’s last day, last week, and last month’s current intraday variation average was 1.10%, 1.04%, and 1.19%, respectively.

Huntington Bancshares’s highest amplitude of average volatility was 1.80% (day), 2.03% (last week), and 2.09% (last month), respectively.

Huntington Bancshares’s Stock Yearly Top and Bottom Value

Huntington Bancshares’s stock is valued at $16.17 at 00:22 EST, below its 52-week high of $16.91 and way above its 52-week low of $11.11.

Huntington Bancshares’s Moving Average

Huntington Bancshares’s worth is above its 50-day moving average of $15.92 and higher than its 200-day moving average of $15.13.

3. First Solar (FSLR)

34.6% sales growth and 9.52% return on equity

First Solar, Inc. provides photovoltaic (PV) solar energy solutions in the United State, Japan, France, Canada, India, Australia, and internationally.

First Solar’s sales growth this year is expected to be 8.1% and a negative 5.7% for next year.

Year-on-year quarterly revenue growth grew by 51%, now sitting on 2.98B for the twelve trailing months.

Volume

Today’s last reported volume for First Solar is 1540980 which is 13.85% below its average volume of 1788760.

First Solar’s sales growth is a negative 0% for the present quarter and 34.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 56.6% and negative -19.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.

Volatility

First Solar’s last day, last week, and last month’s current intraday variation average was 0.53%, 2.81%, and 2.11%, respectively.

First Solar’s highest amplitude of average volatility was 3.26% (day), 5.47% (last week), and 4.36% (last month), respectively.

First Solar’s Stock Yearly Top and Bottom Value

First Solar’s stock is valued at $103.94 at 00:22 EST, way below its 52-week high of $123.13 and way above its 52-week low of $67.71.

First Solar’s Moving Average

First Solar’s value is below its 50-day moving average of $104.92 and way higher than its 200-day moving average of $89.75.

Previous days news about First Solar(FSLR)

  • First tellurium recruits first solar's previous exploration manager and veteran geologist john keller to advisory board. According to Benzinga on Tuesday, 23 November, "The Klondike property was previously owned by First Solar where Mr. Keller worked from 2006 to 2011, initially as a consulting geologist and later as Exploration Manager for North America. ", "Based on those figures, First Solar will likely require significantly more than the 490 metric tons of tellurium that were produced globally in 2020, so increased production of tellurium is necessary, unless significant amounts are stockpiled in warehouses, which does not appear to be the case."

4. Regeneron Pharmaceuticals (REGN)

18.3% sales growth and 51.32% return on equity

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.

Regeneron Pharmaceuticals’s sales growth this year is anticipated to be 56.3% and a negative 10.8% for next year.

Year-on-year quarterly revenue growth grew by 163.2%, now sitting on 12.2B for the twelve trailing months.

Volume

Today’s last reported volume for Regeneron Pharmaceuticals is 564362 which is 25.73% below its average volume of 759934.

Regeneron Pharmaceuticals’s sales growth for the next quarter is 18.3%. The company’s growth estimates for the present quarter and the next is 7.7% and 8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 51.32%.

Volatility

Regeneron Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 0.14%, 0.99%, and 1.60%, respectively.

Regeneron Pharmaceuticals’s highest amplitude of average volatility was 1.54% (day), 2.15% (last week), and 2.67% (last month), respectively.

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $648.51 at 00:22 EST, below its 52-week high of $686.62 and way higher than its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s worth is higher than its 50-day moving average of $592.07 and way above its 200-day moving average of $577.19.

Previous days news about Regeneron Pharmaceuticals(REGN)

  • According to Business Insider on Tuesday, 23 November, "Nykode Therapeutics (VACC), a developer of vaccines and novel immunotherapies, said on Tuesday that it has signed a license and collaboration deal with a potential of over $925 million with Regeneron Pharmaceuticals (REGN), a biotechnology company, for the discovery, development, and commercialization of potential new vaccines for cancer and infectious diseases."

5. Ulta Beauty (ULTA)

15.7% sales growth and 39.86% return on equity

Ulta Beauty, Inc. operates as a beauty retailer in the United States.

Ulta Beauty’s sales growth this year is expected to be 35.2% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 7.66B for the twelve trailing months.

Volume

Today’s last reported volume for Ulta Beauty is 493779 which is 33.26% below its average volume of 739864.

Ulta Beauty’s sales growth is a negative 0% for the current quarter and 15.7% for the next. The company’s growth estimates for the present quarter and the next is 40.2% and 16.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.86%.

Volatility

Ulta Beauty’s last day, last week, and last month’s current intraday variation average was 2.90%, 1.71%, and 1.39%, respectively.

Ulta Beauty’s highest amplitude of average volatility was 3.60% (day), 2.75% (last week), and 2.63% (last month), respectively.

Ulta Beauty’s Stock Yearly Top and Bottom Value

Ulta Beauty’s stock is valued at $405.65 at 00:22 EST, below its 52-week high of $414.98 and way above its 52-week low of $245.62.

Ulta Beauty’s Moving Average

Ulta Beauty’s value is above its 50-day moving average of $378.48 and way above its 200-day moving average of $354.23.

6. CrossAmerica Partners LP (CAPL)

5.9% sales growth and 20.52% return on equity

CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States.

CrossAmerica Partners LP’s sales growth this year is expected to be 67.5% and a negative 10.7% for next year.

Year-on-year quarterly revenue growth grew by 69.7%, now sitting on 2.85B for the twelve trailing months.

Volume

Today’s last reported volume for CrossAmerica Partners LP is 2948 which is 93.3% below its average volume of 44043.

CrossAmerica Partners LP’s sales growth for the next quarter is 5.9%. The company’s growth estimates for the present quarter and the next is a negative 4.2% and 330%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.52%.

Volatility

CrossAmerica Partners LP’s last day, last week, and last month’s current intraday variation average was 2.20%, 1.34%, and 2.09%, respectively.

CrossAmerica Partners LP’s highest amplitude of average volatility was 2.73% (day), 2.61% (last week), and 3.39% (last month), respectively.

CrossAmerica Partners LP’s Stock Yearly Top and Bottom Value

CrossAmerica Partners LP’s stock is valued at $19.19 at 00:22 EST, way under its 52-week high of $23.24 and way above its 52-week low of $16.56.

CrossAmerica Partners LP’s Moving Average

CrossAmerica Partners LP’s value is under its 50-day moving average of $20.54 and under its 200-day moving average of $19.49.

LEAVE A REPLY

Please enter your comment!
Please enter your name here